An FDA-approved cancer therapy blocks drug-resistant HSV-1 by targeting a viral entry pathway. Doxorubicin was shown to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results